Skip to Content

End of year dates: Orders must be billed by 05/12. Merck Mexico will be closed from 18/12 to 02/01.

Merck

Antifungal triazoles induce malformations in vitro.

Reproductive toxicology (Elmsford, N.Y.) (2001-08-08)
E Menegola, M L Broccia, F Di Renzo, E Giavini
ABSTRACT

Triazole-derivatives are antimycotics used in agriculture as well as in clinical and veterinary therapy. The aim of the present work is the in vitro comparative study of the teratogenic activity of triazole (the parental compound), flusilazole (an agricultural triazole mono-derivative fungicide), and fluconazole (a clinically used bis-triazole derivative). Rat embryos, 9.5 days old (1 to 3 somites) were exposed in vitro to triazole 500 to 5000 microM, flusilazole 3.125 to 250 microM, or fluconazole 62.5 to 500 microM. After 48 h in culture, the embryos were morphologically examined and processed for histologic and biochemical analysis. Flusilazole and fluconazole showed similar teratogenic effects (abnormalities at the branchial apparatus level and cell death at the level of the branchial mesenchyme) at concentration levels of 6.25 microM and higher for flusilazole and of 125 microM and higher for fluconazole. By contrast, only slight developmental retardation and blood discoloration were observed at the highest concentrations of triazole, suggesting no teratogenic activity for the triazole group.

MATERIALS
Product Number
Brand
Product Description

Supelco
Flusilazole, PESTANAL®, analytical standard
Product 45753 is not currently sold in your country. Contact Technical Service